Brighthouse Financial Valuation
Is BHF * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BHF * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BHF * (MX$850) is trading above our estimate of fair value (MX$427.16)
Significantly Below Fair Value: BHF * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BHF *?
Other financial metrics that can be useful for relative valuation.
What is BHF *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$2.89b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.1x |
Enterprise Value/EBITDA | n/a |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does BHF *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.9x | ||
GNP * Grupo Nacional Provincial | 0.3x | n/a | Mex$31.3b |
Q * Quálitas Controladora. de | 1.6x | 8.5% | Mex$88.7b |
CNO CNO Financial Group | 0.7x | -0.9% | US$2.9b |
TLI Thai Life Insurance | 1x | 4.1% | ฿105.3b |
BHF * Brighthouse Financial | 0.3x | 1.1% | Mex$2.9b |
Price-To-Sales vs Peers: BHF * is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.6x).
Price to Earnings Ratio vs Industry
How does BHF *'s PE Ratio compare vs other companies in the South American Insurance Industry?
Price-To-Sales vs Industry: BHF * is good value based on its Price-To-Sales Ratio (0.3x) compared to the South American Insurance industry average (0.6x).
Price to Sales Ratio vs Fair Ratio
What is BHF *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.3x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate BHF *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.